Endothelin-1 (ET-1) is an endothelium-derived vasoconstrictor peptide. Animal studies have suggested a possible role of ET-1 in alveolar hypoxia. ET-1 may be of pathophysiological significance in the fetal as well as in the maternal circulation in pregnancies complicated with hypertension. ET-1 has been shown to induce a doserelated constriction in vitro of strips of ductus arteriosus from mature fetal lambs. It has also been shown to contract human umbilical vessels at extremely low concentrations. Its role in the newborn infant is not known.
In the present study we measured plasma ET-1 levels in preterm and term infants soon after birth as well as in healthy infants and children of different ages. ET-1 was determined by a commercial radioimmunoassay kit (RIK 6071, Peninsula Laboratories Europe Ltd).
The plasma levels of ET-1 were as follows (mean, range, pg/ml): preterm (<24 hl 26.8, 11.6-49.2 (n=9) Intravascular transfusion therapy (IVT) is the accepted treatment for severe rhesus iso-immunisation. The timing and frequency of IVT is controversial, and is currently based on change in fetal haematocrit (Hct). The aims of this study were to measure fetal erythropoietin concentration (EPO), haematocrit and red cell volume following serial (IVT) and to study their inter-relationship as anaemia is corrected.
Methods & Results: Twelve pregnancies were studied with serial data in 4 cases. Pre-transfusion fetal EPO correlated inversely with Hct (R2 31%; p = -004) and fell significantly between IVT 1 and IVT 2 (314 to 31 mU/ml:mean values). Bct fell between IVTl and IVT 2 (35 to 25% : mean values n=4). Neither fetal, or donor red cell volumes fell during this time, though circulating fetoplacental blood volume increased (179 to 357 mls: mean values n=4).
Conclusions: Fetal EPO is inversely related to Hct, and is suppressed by IVT through increases in total red cell volume. The fall in Hct between IVT 1 and IVT 2 is due to the physiological increase in fetoplacental blood volume rather than destruction of transfused red cells. i3eliarice i s ~i l d e l y placed cn PCV LC ~rldicnLc lilccd tran:;l'u:iicn requircnjerits c f n e c n a t e s , alLhcugh peer c v e r a l l c c r r e l a t i c n tietween PCV and R C M lias heen demcnstratecl [ L a n c e t . i : 8&-4,1986,) .
'Itie alrn c f t h i s study was LC investigate t h e r c l~t i c n s l i l p beL\.reerl PCV arid RCM with lncreasini( pcst-naLal age I P N A ) 2nd wiLh e s t i n~a l e d haby t c t a l tilccd vclume (TBV).
Pre-triinsfuslcn R C M and I' CV were measured lri l b babies ci' 211 Lc AN INNOVATIVE METHOD FOR NEONATAL AllTOLOGOtIS TRANSFUSION. Robert A . Dracker, Kr:vin Lorah, Anuradlt;~ t ' d l i t , ar~d Ellt!n M . Bifano. SUNYHedlth S c i r n c r C r n l e r , Departments of F "~l l~o l o y y and Pcadiatrics, Syracuse, Ncw York Dul-iny tht: [ i r u t rnonth of l i f e , tiis ~n , r j o r i t y o t very low hirthweight i n f a n t s reqllire nlul t i p l e t r a n s f l l s i c~t~s , thereby r e p e a t e d l y exposing them t o t h e r i s k s of Ihe a d m i r~i s l r a t i o n of t~orsologo~ls i>l(~ird. A~~t o l o y o o s t rarjsf ur;ions r n i r~i r~~i z r t h e risk!; of t r a r~t ; f~l s i o r~ re1;iled i l~f e c L i o n s and r~l l o i~r~n~u r~i z a t i o n .
We hdve developed a nc~vrl syste111 f o r t h e "c.li~sc+d" asc.pti(: c o l l e c t i o n ar~d s t o r a g e o f autoloyous p l a c e r~t a l blood l n s t e r i l e bays c o n t a i n i n g t h ? a n t i c o a g o l ;~r~t , c i t r a t e phosl~hatf! d r x t r c~s e -a d e n i n e .
t < e s u l t s : Of 29 c o l l e c t i o r l s f r u s~ pl~tccnld!; ot v a g i n a l and Cs e c t ion tlrlivc.rie!;, t h e a v e r a g r volustc. o f b l o c~l c:c~llecIc.d was I 6 cc (rdnge 55--110 i:c) over 1 . 5 rnin (r,~r!ye 1 -2 Inin). Rdeqllatc a l l t ic o ; t ( l~~l i~t i o n w.is achieved i n a l l s . i s~p l r s a s drf l n r d by an AfTT > 9 0 s e c . 0vi.r d f o u r wtaek s t o r a g e period a t 4 O C , t h e r e was no s i y n i f icant i n t r<~sds!ple d e c l i n e i n hemoglobio concent r a t ion ( 0 . 4 f 0 . 4 y/dlj; Iuloan cil'l~rgc I s d ) , red blood c e l l A'I'P c o r~t v n t ( 0 . 1 t 0 . 6 ilm/g), cirallyr ill PI, ( 0 . 1 n~rnHq+O. I ) , ini:rr,~c;e i n tlrnlol y!:is O . l i O . l % ) , o r change i l l red ct:ll n~orphology ( 3 i l % e~h i n o c y t e s )
. Surldce c111Iur(?s
All p l a c c r~t a l n u r f a c e cllltllres t a k r r~ a f t e r cord p r e p a r a t i o n a s well a s arrrirrohjc and acsrohic blood c.111 t1lrc.s rrrnairlrd n e g a t i v e over t h e f~i~~r wock s t o r a g e i n t e r v a l .
Con(:l~~t;ion: This study dcroonst r a t e s the, f e a s i l~i l i t y of collc!(:tiny ' 11111 s t o r i n g p l a c e n t a l arrtologous blooil t o r t.ranr;fusions in n(3ondtrs. 1080). 13iih1cs r e c e i v i n g whcle i,lccd t r a n s i ' u s l c n s ntight a l s c prcduce a n t i h c d i e s t c l e u c c c y t e a n t i g e n s e# llL.A, althcuptl In a p1,evicus study c f 13 rnultlply t r a n s f u s e d Inf,ints nc sucll a r l t l h c d i e s were d e t e c t e d ( ' I r a n s f u s l c n 2 0 : 4 1 9 -2 2 , l q R i , ) .
VI I ' L~S L~V C~I I rlectlcltes 4.3' 1 weeI(s gc,:;l , i t i c~i , I -C ,~U I 1,1i,&~, a ? tbl(:cd Li~ansl'usicr~s wer,c3 s t u d i e d l l r c s p e c l l v c l y f c r Ltic dfvclcpment c f anL1-l1l.A a n t l l i c d l e s (aHLAA) a l ' t e r raljdcrnlsitlcn 1.c r e c e l v e e l t h e r whcle hlccd c r l>lccd t r a n s f u s e d v i a a l e u c c c y t e f ' l l t e r .
Antl-IiLAA were measured In MaLernal and ccrd I>lccd and lnjl surnplc:: ilrnwn ~r~cnLt~ly until d1schari.e I'r'cm IicsplLal. DeLeiticn was t,y ~~I I I O I I C (~I C L C X I~ 1Ly r n i c r c t l t r e asL;iy. I?esillL:; wcl.i: chLalned iri 112 haljli-n, 14 In t h e i ' l l t e r . and 23 ill t h e n c -i ' i l t e r Krcup. 1 5 b a b i e s wcre f?xcluded I,ecause el' p r c t c c c l V I C I~~L icri C I , cleat h. NC hahy receivinii 1'1 lLercd tblccd develcped allI.nAs, I>ul. '1 I~a l ? l e s in Ltie n c -r l l L e r jircup d u v~l c p e d allLAAs tp=O.Olfi;>, F~: i l~~? r ' d e x a c t t e s t ) . In ccrli l u s l c n , niultiply transl'used [pretfrrn 1nfarlLs can prcduce anLii>cdies LC IILA, and l e u c c c y l e f~i L~, r s ~r~ay frr,t,ver~t t h i s . 35 weeks g e s t a t l c n , r e c e i v i n g a Lctal c f 36 hlccd t r a n s f u s i c n s . A t a l l a y e s , i c r r e l a t i c n c f PCV with RCM was g r e a t e s t i r i b a b l e s with a TUV 111 t h e ranee '70-00 inl/kg ( r z 0 . 8 2 7 : n z 1 4 ) , ccnlpared Lc t h e s e wlLlr a TUV abcve c r belcw Ltiese v a l u e s ( r~0 .~1 i i O : N=22). In ccricluslcn I' CV i s a p a r t i c u l a r , l y [iccr' ~.:$ii('e c f IiCM l r l pr~eterlll i n f a n t s i n t h e f i r s t 5 d a y s o r l i f e and when t c t a l illccd vclume is n c t i n tile I,nrlce 70-90 ml/ke. q data rolor to IIlu hosp,tal stay, " rnean val~os ol weohly aeternl nauons lrom Ihe lo~rlh to Ine e,ghth we26 Dlllerent s,perscrlpls lndcato ddtoronces at a eve1 lass tnan 0 05.
IRON SUPPLEMENTATION ENHANCES THE RESPONSE TO HIGH DOSES OF RECOMBINANT ERYTHRPOIETIN IN PREMATURE INFANTS.
C c m h s~~ I ) Earlf admm,strdt,on ol h.gh dosos ot E P~W I I~ or w~t h o~t Iron supplemenls rddJces lho need toib.ood transl-son. 2)-lron supp.enrprlt III con,unct,on w.th EPO aoos no1 tunher red-ccl olood lransl~s~ons but yleds nlgner ret~cLlocytes ana hemntocrlts alter the Io~ilh week 01 1.111.31 l~danls treated w.th EPO alone show sgns ol reddcod ~ron stores
